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The purification of histidine-tagged nucleocapsid protein (NP) of Newcastle disease 
virus (NDV) in expanded bed adsorption (EBA) directly from unclarified 
Escherichia coli feedstock was investigated. Streamline 925 Column (ID = 25 mm) 
was used as a contactor and Streamline chelating immobilised with ~ i "  ion was 
used as affinity adsorbent. Unclarified E. coli feedstock of 8% biomass wet mass 
(w/v) was loaded onto the stable expanded bed. 
The adsorption properties of the Streamline chelating were investigated by batch 
adsorption. The adsorption of NP protein onto the Streamline chelating was 
observed to follow the Langmuir isotherm. Optimal binding and elution conditions 
for the application of EBA were developed. Batch binding experiments results 
showed that the optimal pH for adsorption and elution buffer is 8.0. Elution buffer 
which contained 50 mM imidazole was used to remove the unbound proteins and 
elution buffer with 350 mM imidazole was used to elute NP protein from the 
adsorbent. Elution in packed bed column showed that the highest NP protein yield 
was achieved at a flow velocity of 10 crn/h. The bed expansion characteristics of the 
Streamline chelating with buffer and unclarified feedstock were determined by 
visually monitoring the bed height as a function of increasing superficial velocity. 
The dynamic binding capacity of the adsorbent for NP protein was determined in the 
expanded bed column to be 2.9 mg/mL adsorbent. These results were used to 
develop a large scale purification of NP protein in Streamline 25 Column. 
Xi< performance of a conventional purification methodj racked bed adsorption 
(PBA) and EBA for the purification of the NP protein from E. coli feedstock was 
assessed and compared. The conventional way for the recovery of NP proteins 
involved multiple steps such as centrifugation, precipitation, dialysis and sucrose 
gradient ultracentrifugation. For the PBA, feedstock clarified by centrifuge was used 
for column loading, while in EBA; unclarified feedstock was used. The final protein 
yield obtained in conventional and PBA methods was 1.3% and 5.6% respectively. 
It was demonstrated that the EBA achieved the highest final protein yield of 9.6% 
with a purification factor of 6.6. In addition, the total processing time was reduced 
from 56 h to 7.5 h for EBA compared to that of the conventional method. Within the 
range of the experimental works, result from this study suggested that EBA 
technique allowed clarification, concentration and initial purification to be combined 
into a single step operation. The expanded bed purification for NP protein was 
efficient and scalable, promising its implementation in the large scale production of 
proteins. 
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Penulenan secara langsung protein nukleokapsid (NP) virus penyakit Sampar Ayam 
(NDV) yang mengandungi tag enam histidin dari suapan tanpa penjernihan 
Escherichia coli dengan penjerapan lapisan terkembang (EBA) telah diselidiki. 
Kolum Streamline 25 yang berdiameter 25 mrn telah digunakan sebagai kontaktor 
dan Streamline chelating diselat dengan ion nikel telah digunakan sebagai bahan 
jerap afiniti. Suapan tanpa penjernihan E. coli dengan 8% berat basah biojisirn 
(berathsipadu) dimuatkan ke dalam lapisan terkembang yang stabil. 
Ciri penjerapan Streamline chelating telah dikaji dalam penjerapan kelompok. 
Penjerapan protein NP ke atas Streamline chelating yang diperhati adalah mematuhi 
isoterm Langmuir. Keadaan penjerapan dan elusi yang optimum untuk aplikasi 
penjerapan lapisan terkembang telah dibangunkan. Hasil dari ujikaji penjerapan 
kelompok menunjukkan pH 8.0 adalah pH optimum untuk penimbal penjerapan dan 
elusi. Penimbal elusi yang mengandungi 50 mM irnidazol telah digunakan untuk 
mengeluarkan protein yang tidak terjerap manakala penimbal elusi yang 
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mengandungi 350 mM imidazol digunakan untuk memulihkan protein NP dari 
bahan jerap. Elusi dalam lapisan terpadat menunjukkan hasilan protein NP yang 
tertinggi boleh diperolehi pada halaju 10 cmij. Ciri lapisan pengembangan 
Streamline chelating dengan penirnbal and suapan tanpa penjernihan telah diperiksa 
dengan memerhatikan secara visual ketinggian lapisan sebagai h g s i  kepada 
penarnbahan halaju superftsial. Kapasiti dynamik pengikatan bahan jerap untuk 
protein NP telah diperiksa &lam lapisan terkembang dan bernilai 2.9 m g M .  
Penemuan ini akan digunakan untuk membangunkan proses penulenan protein NP di 
kolum Streamline 25 dalam skala besar. 
Prestasi kaedah penulenan konvensional, penjerapan lapisan terpadat (PBA) dan 
EBA untuk penulenan protein NP dari suapan tanpa penjernihan E. coli telah 
diselidiki dan diperband&kan. Cara penulenan secara konvensional untuk 
memulihkan protein NP meliputi pelbagai langkah seperti pengemparan, 
pemendakan, dialisis dan pengemparan kecerunan sukrosa. Dalam PBA, suapan E. 
coli yang dijernihkan dengan pengempar telah digunakan untuk dimuatkan ke dalam 
kolum, sementara dalam EBA, suapan E. coli tanpa penjernihan telah digunakan. 
Hasilan akhir protein yang diperolehi dalam cam penulenan konvensional dan 
kaedah PBA adalah 1.3% dan 5.6% masing-masing. Penulenan secara EBA 
membawa hasilan akhir protein yang tertinggi dengan nilai 9.6% dan factor 
penulenan sebanyak 6.6. Di sarnping itu jumlah masa pemprosesan telah 
disingkatkan dari 56 j ke 7.5 j dalam EBA dibandingkan dengan kaedah penulenan 
konvensional. Dalam lingkungan eksperimen, kajian ini mencadangkan teknik EBA 
membolehkan penggabungan proses penjernihan, pemekatan dan penulenan awal 
kepada satu unit operasi. Penulenan protein NP secara EBA adalah efisien dan boleh 
dinaik-skalakan dan peluang untuk melaksanakan dalam skala besar adalah 
cemerlang. 
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CHAPTER 1 
INTRODUCTION 
The effectiveness of the treatment of a disease is very much depending on the 
delivery of the therapeutic molecules to its target. Various kinds of biological 
molecules have been proposed for use as carrier for the delivery of nucleic acids and 
other therapeutic compounds. The nucleocapsid protein (NP) of a poultry virus, 
Newcastle disease virus (NDV) (Yusoff and Tan, 2001) can be produced in 
Escherichia coli as ring-like structures which has the potential to be used as a 
biocarrier for subunit vaccines development and also as a diagnostic reagent (Kho et 
al., 200 1 ; Rabu et al., 2002). The recombinant NP protein consists of the insertion of 
a hexa-histidine residues on its C-terminus can be expressed abundantly in E. coli 
(Kho, 2003). The engineered histidine tag structures can aid the purification of the 
recombinant protein. Immobilised metal affinity chromatography (MAC) has been 
widely used for the separation of recombinant proteins harbouring histidine-tags 
Veda et al., 2003). The separation is based on the differential affinity of proteins, 
derived from the coordination bonds formed between metal ions and histidine side 
chains exposed on the surface of the protein molecules (Chaga, 2001). 
In the production of therapeutic proteins, the purification process is often 
characterised by a large number of subsequent unit operations, which is not only 
contributed to the fixed and variable costings but also reduce the overall yield of the 
target protein. Up to 80% of the overall cost of a protein production are contributed 
from product recovery processes (Thommes et al., 1996). Downstream processing is 
challenging because the products must be concentrated from a very dilute condition 
in the feedstock and purified fiom other protein impurities having very similar 
properties. The feedstock is generally very complex in nature and contains various 
sizes of dissolved solid, biomass and cell debris. In the conventional way, a final 
product of guaranteed purity and potency can only be achieved with a combination 
of several unit operations (Anspach et al., 1999). Prior to the concentration and 
purification steps, the biomass or cell debris must be separated from the 
fermentation broth or cell homogenate by centrifugation or filtration. In the large- 
scale process of protein recovery, these clarification methods often show limitations 
in practice (Lee, 1989). The more the number of unit operations involved would not 
only cause a longer processing time but also results in higher product loss. Hence, 
the throughput and the final product yield will decrease. Therefore, a single step 
protein purification process that combines feedstock clarification, concentration and 
purification is needed to improve the yields of protein recovery and reduce the 
processing time. 
Expanded bed adsorption (EBA) is a single pass operation in which desired proteins 
are purified from crude, particulate containing feed-stock without the need for 
separate clarification, concentration and initial purification (Chase, 1998; Miyauchi 
et aL, 1998; Sandgathe et aL, 2003). The expansion of the adsorbent bed creates a 
distance between the adsorbent particles, which allows for unhindered passage of 
cells, cell debris and other particulates during application of crude feedstock to the 
column (Hjorth, 1997). The EBA has been proven to be a versatile tool that can be 
applied on all commonly used source materials such as E. coli (Clemmitt and Chase, 
2000a; Cho et al., 2002), yeast homogenates (Chang and Chase, 1996b; Willoughby 
et al., 1999), hybridoma cell (Thornrnes et al., 1995a), mammalian cell culture fluid 
(Batt et al., 1995) and transgenic milk (Degener et al., 1998). 
Currently, the NP protein was purified in the laboratory scale by a four step 
conventional method which involving centrifugation, precipitation, dialysis and 
sucrose gradient ultracentrifugation (Kho, 2003). However, there was no literature 
report on the purification of the NP protein using EBA chromatography. Due to the 
wide application of NP protein, there is a need to produce and purify this protein in 
large scale. Hence, the prime aim of this study was to develop a simplified method 
for fast and cost effective purification process of the recombinant NP protein. The 
combination of EBA and IMAC would result in a simple and efficient protein 
purification process. Therefore, the objectives of the present study were: 
1) Optimisation of the capture of NP protein onto IMAC adsorbent from 
clarified and unclarified feedstock. 
Optimisation of the elution of NP protein fiom MAC adsorbent. 
Development and optimisation of a packed bed chromatography for the 
purification of NP protein fiom clarified feedstock. 
Development and optimisation of an EBA chromatography for the 
purification of NP protein from unclarified feedstock. 
The final protein yield, purity and purification factor from EBA chromatography 
would be compared with that of packed bed adsorption (PBA) and conventional 
purification method. 
CHAPTER 2 
LITERATURE REVIEW 
2.1 Nucleocapsid Protein (NP) of Newcastle Disease Virus (NDV) 
2.1.1 Recombinant Protein 
The development of recombinant DNA techniques presents a great opportunity for 
the integration of the 'upstream' gene cloning steps and 'downstream' protein 
purification operations. Production of recombinant protein has been successfully 
performed in several host systems, such as E. coli (Gibert et al., 2000), yeast 
(Raymond et al., 1998), insect (Michel et al., 2001) and mammalian cells (Batt et 
al., 1995). E. coli has been the popular choice of host because a wide choice of 
cloning vectors is available, large yields of recombinant protein, easy to grow and 
recombinant proteins can be expressed as fusion proteins (Pharmacia Biotech, 
1993). 
Expression vectors have been developed where the expressed protein is fused to a 
protein of known composition so that the product can be easily captured by a highly 
specific affinity chromatography step prior to further purification (Jonasson et al., 
2002). For example, the histidine-tagged fusion protein can be recovered by using 
IMAC, which will be discussed in detail in section 2.3. The application of IMAC 
together with EBA chromatography can simplify the recovery process by integrating 
several unit operations such as clarification, concentration and initial purification, 
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thereby increasing the overall efficiency in the downstream purification process (Hu 
et al., 2003; Ueda et al., 2003). 
2.1.2 Studies on the Recombinant NP Protein 
Newcastle disease virus (NDV) is the prototype of the Paramyxoviridae family and 
the causal agent of the major disease outbreak in avian species worldwide (Seal et 
al., 2000). NDV contains a linear single-stranded RNA of negative polarity, which is 
associated with the nucleocapsid protein (NP), phosphoprotein (P), matrix protein 
(M), h i o n  protein (F), haemaglutinin-neuraminidase (HN) and large proteins (L) 
(Seal et al., 2000; Yusoff and Tan, 200 1). 
The NP protein is the most abundant of the viral proteins and plays a prominent role 
in viral replication (Kho et al., 2003). The NP proteins of many viruses are highly 
conserved, immunogenic and abundantly expressed during infection. These features 
enabled their potential uses as diagnostic reagents, such as enzyme-linked 
immunosorbent assays (ELISA) (Errington et al., 1995; Rabu et al., 2002). Kho et 
al. (2001) reported that the NP protein on NDV produced in E. coli assembled into 
ring-like particles and the insertion of a 29 amino acid peptide including the myc 
epitope and a hexa-histidine tag into the C-terminus of the NP protein did not impair 
ring-like assembly of the viral nucleocapsid. These extra amino acid sequences were 
shown to be exposed on the surface of the ring-like particles, suggesting that the 
particle can be used as a molecular carrier for presenting desired epitopes in the 
development of subunit vaccines (Kho et al., 2001; Kho, 2003). 
Errington et al. (1995) have discovered earlier that the NP protein of NDV was 
antigenic and could be used in ELISA to detect the presence of anti-NDV 
antibodies. These results indicated the potential of the NP protein as a diagnostic 
reagent in ELISA. For example, the recent outbreak of the novel coronavirus, Severe 
Acute Respiratory Syndrome (SARS-CoV) has utilised this potential in its 
diagnosis. Tirnani et al. (2004) noted that the NP protein of SARS-CoV is highly 
immunogenic and has successfully been used in ELISA for detecting the antibodies 
for the sero-diagnosis of SARS. Other examples of the nucleocapsid proteins of 
viruses, such as mumps (Slibinskas et al., 2003), rabies (Reid-Sanden et al., 1990), 
measles (Samuel et al., 2003) and infectious bronchitis virus (Seah et al., 2000) 
were shown to have the potential to be developed as a diagnostic reagent. 
2.1.3 Purification Processes 
NP protein of NDV has been reported to be successfully expressed abundantly in E. 
coli (Rabu et al., 2002; Kho et al., 2003) and baculovirus (Errington et al., 1995) 
and many researches have reported on the study of the hnctionality of the 
possibility to use NP protein as a diagnostic reagent. However, there are not many 
published data on the purification of the NP protein expressed in recombinant hosts. 
In general, the NP protein was purified conventionally with cesium chloride gradient 
ultracentrifugation (Slibinskas et al., 2003; Juozapaitis et al., 2005). Slibinskas et a1 
(2004) reported that the NP protein expressed in yeast, was first purified with 
sucrose gradient ultracentrifugation for 3 h, followed by cesium chloride gradient 
